Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia

被引:26
作者
Aydin, O [1 ]
Dusmez, D
Cinel, L
Doruk, E
Kanik, A
机构
[1] Mersin Univ, Dept Pathol, Sch Med, TR-33070 Mersin Icel, Turkey
[2] Mersin Univ, Dept Urol, Sch Med, TR-33070 Mersin Icel, Turkey
[3] Mersin Univ, Dept Biostat, Sch Med, TR-33070 Mersin Icel, Turkey
关键词
mast cells; prostate;
D O I
10.1078/0344-0338-00253
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recently, some studies reported the presence of mast cells in various malignancies and their role in tumor growth. The aim of the study was to determine the utility of mast cell numbers in evaluating benign and malignant prostate lesions, and to ascertain whether there are variations in the numbers of mast cells with the Gleason grade. The relationship between mast cell numbers and patient age was also investigated. Retrospectively, 104 prostate specimens were examined for the presence of mast cells. The study group consisted of 57 benign prostatic hyperplasias and 47 prostate carcinomas. The paraffin sections were stained with anti-human mast cell tryptase immunohistologically. The numbers of positively staining cells in five high-power fields were counted, and their mean was calculated. There was no relationship found between mast cell numbers and age statistically. The mean mast cell numbers of the intratumoral region were significantly different from those of the peritumoral region (p = 0.0001). While the difference between benign hyperplasia and the intratumoral region was found to be significant (p = 0.0001), no difference between hyperplasia and the peritumoral region was noted (p = 0.762). There was no statistical difference between Gleason score groups (p = 0.452), and there was no interaction between score groups and intraperitumoral regions (p = 0.355).
引用
收藏
页码:267 / 271
页数:5
相关论文
共 31 条
[1]  
Abe M, 1998, CLIN EXP ALLERGY, V28, P1509
[2]  
Amir T, 1998, Indian J Med Sci, V52, P507
[3]   Characterisation of inflammatory cells in benign prostatic hyperplasia [J].
Anim, JT ;
Udo, C ;
John, B .
ACTA HISTOCHEMICA, 1998, 100 (04) :439-449
[4]  
CRAIG SS, 1986, AM J PATHOL, V124, P427
[5]   MAST-CELLS AND MATRIX DEGRADATION AT SITES OF TUMOR INVASION IN RAT MAMMARY ADENOCARCINOMA [J].
DABBOUS, MK ;
WALKER, R ;
HANEY, L ;
CARTER, LM ;
NICOLSON, GL ;
WOOLLEY, DE .
BRITISH JOURNAL OF CANCER, 1986, 54 (03) :459-465
[6]  
Dimitriadou V, 1997, ANTICANCER RES, V17, P1541
[7]  
Epstein JI, 1999, DIAGNOSTIC SURG PATH, P1893
[8]   PROLIFERATION OF MAST-CELLS IN NORMAL AND DMBA-TREATED MOUSE SKIN [J].
FARNOUSH, A ;
MACKENZIE, IC .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1984, 13 (04) :359-365
[9]   MOUSE MAST-CELLS AS ANTI-TUMOR EFFECTOR-CELLS [J].
FARRAM, E ;
NELSON, DS .
CELLULAR IMMUNOLOGY, 1980, 55 (02) :294-301
[10]  
FISHER ER, 1965, ARCH PATHOL, V79, P185